New AI eye screening tool could help millions with diabetes avoid blindness
NCT ID NCT06343350
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tested a software called OPTDR01 that automatically checks retinal images for signs of diabetic retinopathy, a leading cause of vision loss. Researchers enrolled 300 adults with diabetes to see if the tool is easy to use and practical in a clinic setting. The goal is to make screening more available in primary care, especially for underserved groups who often miss annual eye exams.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gastro SB
Chula Vista, California, 91910, United States
-
Gulf Coast Clinical Research
Houston, Texas, 77070, United States
-
Triwest Research Associates
San Diego, California, 92108, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OPTDR01 software application
What this could lead to
If successful, this tool could make diabetic retinopathy screening more accessible in primary care, helping catch the disease early and prevent vision loss.
What could go wrong
This is a small pilot study focused on usability and feasibility, not on clinical outcomes. The tool may not be accurate enough or practical for widespread use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.